Real-time enrollment status for this inclisiran formulation clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:08 PM UTC
| NCT Number | NCT07626281 |
| Recruiting Status | Recruiting |
| Condition | Inclisiran Formulation |
| Phase | PHASE1 |
| Target Enrollment | 120 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 10, 2026 (6 days ago) |
As of July 16, 2026: Clinical trial NCT07626281 is currently recruiting participants. This phase1 study for inclisiran formulation is actively seeking new participants at 3 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07626281 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07626281 was last updated 6 days ago (July 10, 2026). HelloStudys verifies this status automatically.